This brand name is authorized in Nigeria. It is also authorized in Ireland, UK.
The drug PIRITON contains one active pharmaceutical ingredient (API):
1
|
UNII
V1Q0O9OJ9Z - CHLORPHENIRAMINE MALEATE
|
Chlorphenamine is a potent antihistamine (H1-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H1-receptor sites on tissues. Chlorphenamine also has anticholinergic activity. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
04-0252 | Tablet | PIRITON TABLET TAB 4 mg 1 x 250tablets | PIRITON TABLET CHLORPHENIRAMINE MALEATE Chlorpheniramine maleate BP 4mg 04-0252 Drugs Nigerian Products tablet1pack Over The Counter (OTC) 17/04/2020 EVANS BAROQUE LIMITED, LAGOS BADAGRY EXPRESS WAY, AGBARA INDUSTRIAL ESTATE, AGBARA, OGUN STATE ISOLO LAGOS 8033304149 regulatory@evansbaroque.com EVANS BAROQUE LIMITED, KM. 32, LAGOS-BADAGRY EXPRESSWAY, AGBARA INDUSTRIAL ESTATE, AGBARA, OGUN STATE, Nigeria | 31/08/2023 |
04-0437 | Syrup | PIRITON SYRUP SYRUP 2 mg 60ML | 48 RNW-PP-126858 PIRITON SYRUP CHLORPHENIRAMINE MALEATE Chlorpheniramine maleate 2mg 04-0437 Drugs RESPIRATORY SYSTEM Nigerian Products 60ml Prescription Only Medicine (POM) 4/17/2020 EVANS BAROQUE LIMITED, LAGOS BADAGRY EXPRESS WAY, AGBARA INDUSTRIAL ESTATE, AGBARA, OGUN STATE ISOLO LAGOS 8033304149 regulatory@evansbaroque.com EVANS MEDICALPLC, KM. 32, LAGOS-BADAGRY EXPRESSWAY, AGBARA INDUSTRIAL ESTATE, AGBARA, OGUN STATE, Nigeria | 06/07/2023 |
Below package inserts are available for further reading:
Document | Type | Information Source | |
---|---|---|---|
PIRITON Tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
R06AB02 | Dexchlorpheniramine | R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AB Substituted alkylamines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
GB | Medicines & Healthcare Products Regulatory Agency | 132026, 15742, 15760, 23537 |
NG | Registered Drug Product Database | 04-0252, 04-0437 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.